Decreased Epstein-Barr virus-induced transformation, and elevated 2-5A synthetase and RNase L activity in peripheral blood mononuclear cells from patients treated with recombinant interferon alfa 2b.

[1]  V. Fazio,et al.  HTLV-V: a new human retrovirus isolated in a Tac-negative T cell lymphoma/leukemia. , 1987, Science.

[2]  E. Vonderheid,et al.  Recombinant interferon alfa-2b in plaque-phase mycosis fungoides. Intralesional and low-dose intramuscular therapy. , 1987, Archives of dermatology.

[3]  J. Sullivan,et al.  Immunoregulation during acute infection with Epstein-Barr virus: dynamics of interferon and 2',5'-oligoadenylate synthetase activity. , 1985, The Journal of infectious diseases.

[4]  P. Altmeyer,et al.  Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application. , 1985, Journal of interferon research.

[5]  D. Carson,et al.  Regulation of Epstein‐Barr virus infection by recombinant interferons. Selected sensitivity to interferon‐γ , 1985, European journal of immunology.

[6]  A. Lerner,et al.  Pharmacokinetics and tolerance of intravenous and intramuscular recombinant alpha2 interferon in patients with malignancies , 1984, American journal of hematology.

[7]  I. Kerr,et al.  Activation of the ppp(A2'p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2'p)nA-dependent RNase. , 1984, European journal of biochemistry.

[8]  J. Mosca,et al.  Increased 2',5'-oligoadenylate synthetase activity in blood mononuclear leukocytes from patients with advanced cutaneous T-cell lymphoma. , 1984, Clinical immunology and immunopathology.

[9]  R. Schooley,et al.  Prevention of Epstein-Barr virus-induced B-cell outgrowth by interferon alpha , 1984, Infection and immunity.

[10]  E. Vonderheid,et al.  2',5'-oligoadenylate synthetase from cutaneous T-cell lymphoma: biosynthesis, identification, quantitation, molecular size of the 2',5'-oligoadenylates, and inhibition of protein synthesis. , 1983, Biochemistry.

[11]  M. Robert-Guroff,et al.  A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. , 1982, Science.

[12]  P. Doetsch,et al.  Inhibition of Epstein-Barr virus-associated nuclear antigen (EBNA) induction by (2',5')oligoadenylate and the cordycepin analog: mechanism of action for inhibition of EBV-induced transformation. , 1982, Virology.

[13]  I. Kerr,et al.  Control of the ppp(a2'p)nA system in HeLa cells. Effects of interferon and virus infection. , 1982, European journal of biochemistry.

[14]  T. Hahn,et al.  Evaluation of the human interferon system in viral disease. , 1981, Clinical and experimental immunology.

[15]  W. Summers,et al.  Genome of a mononucleosis epstein-barr virus contains DNA fragments previously regarded to be unique to Burkitt's lymphoma isolates , 1981, Cell.

[16]  I. Kerr,et al.  Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2'p)nA) in interferon-treated cells. , 1981, Nucleic acids research.

[17]  D. Wallach,et al.  The interferon-induced enzyme oligo-isoadenylate synthetase: rapid determination of its in vitro products. , 1981, Analytical biochemistry.

[18]  J. Robinson,et al.  Efficiency of transformation of lymphocytes by Epstein-Barr virus. , 1977, Virology.